Category
Earnings & Investor News press releases
285 releases
Aprea Therapeutics Announces Third Quarter 2026 Financial Results
Updated interim Phase 1 data for oral WEE1 inhibitor APR-1051 to be featured in an oral presentation at the 38th EORTC-NCI-AACR Symposium (ENA 2026)…
Twin Disc Announces First Quarter Results
GRAINGER REPORTS RESULTS FOR THE THIRD QUARTER 2026
Continued strong results across the business; Company increases full year 2026 earnings outlook Third Quarter Highlights Delivered sales of $5.2…
Creative Planning Acquires Rockbridge Investment Management, Expanding Financial Planning and Wealth Management for Syracuse-Area Families
Creative Planning, LLC ("Creative Planning"), one of the nation's largest independent wealth management firms, today announced it has acquired…
Peabody Board Declares Dividend on Common Stock
Peabody (NYSE: BTU) announced today that its Board of Directors has declared a quarterly dividend on its common stock of $0.075 per share, payable on…
NNN REIT, Inc. Announces Third Quarter 2026 Results
NNN REIT, Inc. (NYSE: NNN) (the "Company" or "NNN"), a real estate investment trust, today announced financial and operating results for the quarter…
Southwest Gas Holdings, Inc. Reports Third Quarter 2026 Financial Results, Reaffirms Full-Year 2026 Guidance
Delivered 8.0% Twelve-month-ended Utility ROE Company Completes Nevada and California Rate Cases as Arizona Rate Case Progresses Great Basin 2028…
Ocugen Provides Business Update with Third Quarter 2026 Financial Results
Conference Call and Webcast Today at 8:30 a.m. ET
MADISON SQUARE GARDEN ENTERTAINMENT CORP. REPORTS
FISCAL 2027 FIRST QUARTER RESULTS
FOSTER L B CO
Talphera to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026
Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative…
Vishay Intertechnology Reports Third Quarter 2026 Results
DISCO Announces Third Quarter 2026 Financial Results
Total Revenue of $45.3 Million, A Year over Year Increase of 11%, or 15% when Excluding the Contingent Matter in Q3 2025
SERES THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND ANNOUNCES PLANS FOR ADVANCING DEVELOPMENT OF SER-155 TO PREVENT IMMUNE CHECKPOINT INHIBITOR-RELATED ENTEROCOLITIS (irEC)
Prevention approach aims to keep patients on immune checkpoint inhibitor (ICI) therapy and avoid immunosuppressive irEC treatments, representing an…
Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update
-- Multiple New Business Wins Continue to Strengthen Growing Pipeline --
Performance Food Group Co
Performance Food Group Company Reports First-Quarter Fiscal 2027 Results
MARRIOTT VACATIONS WORLDWIDE Corp
Marriott Vacations Worldwide Reports




